Pmprb Guidelines Scoping Paper

DOWNLOAD

Download Pmprb Guidelines Scoping Paper PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Pmprb Guidelines Scoping Paper book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page

Pmprb Guidelines Scoping Paper

DOWNLOAD
Author :
language : en
Publisher:
Release Date : 2017

Pmprb Guidelines Scoping Paper written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017 with categories.

Pmprb Guidelines Scoping Paper

DOWNLOAD
Author : Canada. Conseil d'examen du prix des médicaments brevetés
language : en
Publisher:
Release Date : 2017

Pmprb Guidelines Scoping Paper written by Canada. Conseil d'examen du prix des médicaments brevetés and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017 with categories.

Making Medicines Affordable

DOWNLOAD
Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2018-03-01

Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-01 with Medical categories.

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Promoting Access To Medical Technologies And Innovation Intersections Between Public Health Intellectual Property And Trade

DOWNLOAD
Author : World Intellectual Property Organization
language : en
Publisher: WIPO
Release Date : 2013

Promoting Access To Medical Technologies And Innovation Intersections Between Public Health Intellectual Property And Trade written by World Intellectual Property Organization and has been published by WIPO this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013 with Law categories.

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.

Pharmaceutical Prices In The 21st Century

DOWNLOAD
Author : Zaheer-Ud-Din Babar
language : en
Publisher: Springer
Release Date : 2014-12-05

Pharmaceutical Prices In The 21st Century written by Zaheer-Ud-Din Babar and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-12-05 with Business & Economics categories.

This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.

Building On Values

DOWNLOAD
Author : Commission on the Future of Health Care in Canada
language : en
Publisher: Saskatoon : Commission on the Future of Health Care in Canada
Release Date : 2002

Building On Values written by Commission on the Future of Health Care in Canada and has been published by Saskatoon : Commission on the Future of Health Care in Canada this book supported file pdf, txt, epub, kindle and other format this book has been release on 2002 with Medical categories.

In April 2001, the Prime Minister established the Commission on the Future of Health Care in Canada. Its mandate was to review medicare, engage Canadians in a national dialogue on its future, and make recommendations to enhance the system's quality and sustainability. The 47 recommendations in this report outline actions that must be taken in 10 critical areas, starting by renewing the foundations of medicare and considering Canada's role in improving health around the world.

Health Systems In Transition Third Edition

DOWNLOAD
Author : Gregory P. Marchildon
language : en
Publisher: University of Toronto Press
Release Date : 2021-04-21

Health Systems In Transition Third Edition written by Gregory P. Marchildon and has been published by University of Toronto Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2021-04-21 with Health care reform categories.

This book provides insight into how the Canadian health care system is financed and organized, how it has evolved over time, and how well it performs relative to peer countries.

Public Health Innovation And Intellectual Property Rights

DOWNLOAD
Author :
language : en
Publisher: WHO
Release Date : 2006-01-01

Public Health Innovation And Intellectual Property Rights written by and has been published by WHO this book supported file pdf, txt, epub, kindle and other format this book has been release on 2006-01-01 with HEALTH & FITNESS categories.

The Commission was established by the World Health Assembly in 2003 to: "...collect data and proposals from the different actors involved and produce an analysis of intellectual property rights, innovation, and public health, including the question of appropriate funding and incentive mechanisms for the creation of new medicines and other products against diseases that disproportionately affect developing countries..." This report looks at the process of innovation, the path to application and the ways of getting products to patients, ways of fostering innovation in developing countries, and ways to promote both innovation and access

From Research To Reality

DOWNLOAD
Author : The Expert Panel on the Approval and Use of Somatic Gene Therapies in Canada
language : en
Publisher: Council of Canadian Academies
Release Date : 2020-11-05

From Research To Reality written by The Expert Panel on the Approval and Use of Somatic Gene Therapies in Canada and has been published by Council of Canadian Academies this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-11-05 with Medical categories.

From Research to Reality describes the stages involved in the approval and use of gene therapies in Canada, and examines challenges associated with regulatory oversight, manufacturing, access, and affordability, and identifies promising approaches to address them.

Orphan Drugs And Rare Diseases

DOWNLOAD
Author : David C Pryde
language : en
Publisher: Royal Society of Chemistry
Release Date : 2014-07-30

Orphan Drugs And Rare Diseases written by David C Pryde and has been published by Royal Society of Chemistry this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-07-30 with Science categories.

Orphan drugs are designated drug substances that are intended to treat rare or ‘orphan’ diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world’s population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.